$16.86
-0.69-3.93%
In chiusura: Nov 19, 4:00 PM EST
$16.86
N/A
After hour: 4:00 PM EST
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Keros Therapeutics Inc (NASDAQ:KROS) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 3.82M a 5.86M. Questo rappresenta il 37.16% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 1.08M azioni scambiate al giorno, ci vorrebbero 5.41 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
5.86M
Vendite allo scoperto %
37.2%
Giorni di copertura
5.41
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
KROS | Keros Therapeutics, Inc. Commo | 10/31/2025 | 11/11/2025 | 37.16% | 15,774,651 | 5,862,479 | 1,084,229 | 5.41 | |
KROS | Keros Therapeutics, Inc. Commo | 10/15/2025 | 10/24/2025 | 24.20% | 15,774,651 | 3,817,848 | 1,001,572 | 3.81 | |
KROS | Keros Therapeutics, Inc. Commo | 09/30/2025 | 10/09/2025 | 14.92% | 25,923,996 | 3,867,988 | 322,739 | 11.98 | |
KROS | Keros Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 17.81% | 25,923,996 | 4,617,384 | 321,633 | 14.36 | |
KROS | Keros Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 17.36% | 25,923,996 | 4,501,318 | 543,817 | 8.28 | |
KROS | Keros Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 18.65% | 25,923,996 | 4,834,554 | 433,368 | 11.16 | |
KROS | Keros Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 18.67% | 25,923,996 | 4,841,195 | 452,983 | 10.69 | |
KROS | Keros Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 19.48% | 25,923,996 | 5,049,215 | 437,402 | 11.54 | |
KROS | Keros Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 19.92% | 25,923,996 | 5,164,330 | 502,445 | 10.28 | |
KROS | Keros Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 18.14% | 25,923,996 | 4,702,282 | 757,084 | 6.21 | |
KROS | Keros Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 20.47% | 25,923,996 | 5,306,156 | 576,856 | 9.2 | |
KROS | Keros Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 22.27% | 25,923,996 | 5,772,258 | 828,239 | 6.97 | |
KROS | Keros Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 20.31% | 25,923,996 | 5,266,448 | 1,096,189 | 4.8 | |
KROS | Keros Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | 17.01% | 25,919,996 | 4,407,820 | 1,850,318 | 2.38 | |
KROS | Keros Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 13.60% | 29,803,710 | 4,053,717 | 664,202 | 6.1 | |
KROS | Keros Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 13.49% | 29,803,710 | 4,019,396 | 806,671 | 4.98 | |
KROS | Keros Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 14.03% | 29,803,710 | 4,182,765 | 1,084,023 | 3.86 | |
KROS | Keros Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 13.89% | 29,749,072 | 4,132,154 | 1,050,769 | 3.93 | |
KROS | Keros Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 14.32% | 29,749,072 | 4,259,099 | 1,823,869 | 2.34 | |
KROS | Keros Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 13.51% | 29,749,072 | 4,017,848 | 2,432,437 | 1.65 | |
KROS | Keros Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 14.50% | 29,749,072 | 4,313,793 | 1,351,442 | 3.19 | |
KROS | Keros Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 10.17% | 29,749,072 | 3,025,140 | 2,354,386 | 1.28 | |
KROS | Keros Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 7.39% | 29,749,072 | 2,197,295 | 378,448 | 5.81 | |
KROS | Keros Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 7.48% | 29,749,072 | 2,224,037 | 458,829 | 4.85 | |
KROS | Keros Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 8.11% | 29,749,072 | 2,412,173 | 313,386 | 7.7 | |
KROS | Keros Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 10.17% | 26,763,760 | 2,721,108 | 295,480 | 9.21 | |
KROS | Keros Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 11.28% | 26,763,760 | 3,017,784 | 402,445 | 7.5 | |
KROS | Keros Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 13.07% | 26,763,760 | 3,497,638 | 424,517 | 8.24 | |
KROS | Keros Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 12.75% | 26,763,760 | 3,412,592 | 236,304 | 14.44 | |
KROS | Keros Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 11.84% | 26,763,760 | 3,168,631 | 361,132 | 8.77 | |
KROS | Keros Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 11.32% | 25,325,549 | 2,868,048 | 351,145 | 8.17 | |
KROS | Keros Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 10.07% | 25,325,549 | 2,551,304 | 553,148 | 4.61 | |
KROS | Keros Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 10.29% | 25,325,549 | 2,606,491 | 320,308 | 8.14 | |
KROS | Keros Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 9.28% | 25,325,549 | 2,349,769 | 247,838 | 9.48 | |
KROS | Keros Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 9.58% | 25,325,549 | 2,426,877 | 298,167 | 8.14 | |
KROS | Keros Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 9.04% | 25,325,549 | 2,288,476 | 294,836 | 7.76 | |
KROS | Keros Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 8.92% | 25,309,449 | 2,256,483 | 230,271 | 9.8 | |
KROS | Keros Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 8.41% | 25,012,443 | 2,102,503 | 335,370 | 6.27 | |
KROS | Keros Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 7.69% | 25,012,443 | 1,923,624 | 487,525 | 3.95 | |
KROS | Keros Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 7.23% | 25,012,443 | 1,807,214 | 371,268 | 4.87 | |
KROS | Keros Therapeutics, Inc. Commo | 02/15/2024 | 02/27/2024 | 7.74% | 23,014,193 | 1,781,728 | 427,584 | 4.17 | |
KROS | Keros Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 7.68% | 23,014,193 | 1,767,499 | 389,425 | 4.54 | |
KROS | Keros Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 6.31% | 23,014,193 | 1,452,920 | 736,144 | 1.97 | |
KROS | Keros Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 5.96% | 23,014,193 | 1,371,281 | 359,737 | 3.81 | |
KROS | Keros Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 7.70% | 18,989,193 | 1,462,238 | 507,055 | 2.88 | |
KROS | Keros Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 7.61% | 18,989,193 | 1,444,185 | 233,817 | 6.18 | |
KROS | Keros Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 6.44% | 18,989,193 | 1,222,226 | 326,441 | 3.74 |
In cerca di azioni più vendute allo scoperto?